You have access
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
NAOKI FUKUDA, KAZUHISA TODA, YU FUJIWARA, XIAOFEI WANG, AKIHIRO OHMOTO, TETSUYA URASAKI, NAOMI HAYASHI, YASUYOSHI SATO, KENJI NAKANO, MAYU YUNOKAWA, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI
In Vivo September 2020, 34 (5) 2859-2864; DOI: https://doi.org/10.21873/invivo.12113